WHO publishes new guidelines on HIV, hepatitis and STIs for key populations

WHO publishes new guidelines on HIV, hepatitis and STIs for key populations

The World health Organisation (WHO has published new “Consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations.”

The guidelines are officially launched at the AIDS 2022 Conference in Montreal, Canada, in a satellite session entitled: Launching new WHO guidelines for key populations: Focus for impact. 

The guidelines outline a public health response to HIV, viral hepatitis and sexually transmitted infections (STIs) for 5 key populations (men who have sex with men, trans and gender diverse people, sex workers, people who inject drugs and people in prisons and other closed settings). 

WHO promotes an evidence and rights based approach to addressing these health issues which puts key populations at the centre of the response.

“Key populations must be prioritized, in every setting and this means as outlined in these new guidelines, planning to reach them first with prevention, testing and treatment as well as prioritizing key populations in funding programmes,” said Erika Castellanos, Director of programmes at GATE (the global Action for Trans Equality), who was the co-chair of the WHO Guidelines Development Group.   

Particularly for key populations, social, legal, structural and other contextual factors both increase vulnerability to HIV, viral hepatitis and STIs and obstruct access to health and other essential services. These guidelines highlight the critical importance of addressing structural barriers in all settings as a priority.  

“The new data from UNAIDS show that around 70% of new HIV infections occur among key populations and their partners. In most countries, limited access, inadequate coverage and poor quality of services for key populations continue to undermine responses to HIV, viral hepatitis and STIs,” said Meg Doherty, Director of WHO’s Global HIV, Hepatitis and STI Programmes. “All countries should prioritize reaching these key populations and supporting key population communities to lead the response and provide equitable, accessible and acceptable services to these groups.”  

In addition to highlighting the need to address structural barriers and provide prioritized packages of health services for each of the 5 populations, new recommendations are made for the delivery of services such as virtual/on-line interventions and the critical role of peer navigators to guide members of key population groups through health services. 

Other new areas of recommendations include addressing chemsex, frequency of hepatitis C virus (HCV) testing for people at ongoing risk of infection and providing treatment for HCV without delay to people with recently acquired HCV infection and ongoing risk. These guidelines also acknowledge that behavioural interventions aimed at changing behaviours – which tend to be prioritized in many settings – have no impact on incidence of HIV, viral hepatitis and STIs or on behaviour change. 

About author

You might also like


NAFDAC, Customs  release lab report on ‘Plastic Rice

Not plastic but contains microorganisms above permissible limit Not fit for human consumption Consignment to be destroyed by Customs The National Agency for Food and Drug Administration and Control (NAFDAC)

EKO Hospital set to offer quality care with approval of 110,000,000 shares

To ensure that EkoCorp Plc owner of Eko Hospital delivers adequate healthcare and contribute it’s quota to solving some of the challenges bedeviling healthcare delivery in Nigeria, the company on

China FDA slams 3 drug firms

… orders recall of products. China FDA has ordered 3 drug makers to recall certain products off the shelf in the latest effort to enforce good manufacturing practices (GMP) on


No Comments Yet!

You can be first to comment this post!

Leave a Reply